Form EFFECT Kezar Life Sciences,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 14, 2026 |
| Accession Number: | 0001140361-26-020547 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 14, 2026 |
| Accession Number: | 0001140361-26-020547 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||